CANADA LIFE ASSURANCE Co - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 120 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
CANADA LIFE ASSURANCE Co ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$34,000
-10.5%
10,0000.0%0.00%
Q2 2018$38,000
-7.3%
10,0000.0%0.00%
Q1 2018$41,000
-10.9%
10,0000.0%0.00%
Q4 2017$46,000
-35.2%
10,0000.0%0.00%
Q3 2017$71,000
-1.4%
10,0000.0%0.00%
Q2 2017$72,000
+18.0%
10,0000.0%0.00%
Q1 2017$61,000
+3.4%
10,0000.0%0.00%
Q4 2016$59,000
-44.3%
10,000
-50.0%
0.00%
Q3 2016$106,000
+60.6%
20,000
+100.0%
0.00%
Q2 2016$66,000
+43.5%
10,0000.0%0.00%
Q1 2016$46,000
-9.8%
10,0000.0%0.00%
Q4 2015$51,000
+45.7%
10,0000.0%0.00%
Q3 2015$35,000
-65.0%
10,0000.0%0.00%
Q2 2015$100,000
-21.3%
10,0000.0%0.00%
Q1 2015$127,000
-9.9%
10,0000.0%0.00%
Q4 2014$141,000
+2.2%
10,0000.0%0.00%
Q3 2014$138,000
-9.8%
10,0000.0%0.00%
-100.0%
Q2 2014$153,00010,0000.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Old West Investment Management, LLC 1,068,719$3,633,0001.50%
Abrams Capital Management 9,108,867$30,970,0000.82%
Baupost Group 25,791,678$87,692,0000.67%
Bristol Advisors, LLC 51,100$174,0000.29%
RICE HALL JAMES & ASSOCIATES, LLC 2,228,059$7,575,0000.27%
NEXTHERA CAPITAL LP 200,000$680,0000.13%
LINCOLN CAPITAL CORP 37,280$127,0000.10%
Meridian Wealth Management, LLC 49,600$169,0000.07%
Rubric Capital Management LP 199,883$680,0000.07%
Virtus ETF Advisers LLC 155,009$527,0000.05%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders